UHN Chief Executive Kevin Smith stated, 'We are incredibly proud to be at the forefront of this research advancement in neurosurgery.' This highlights the significance of the clinical trials for Neuralink.
Neuralink is now looking for its first patients in Canada, specifically targeting quadriplegic individuals due to ALS or spinal cord injury, aiming to improve their quality of life.
The company plans to assess the safety and initial functionality of its brain implant, which aims to address conditions ranging from paralysis to mental health disorders.
Following the first human implant last September, Neuralink is expanding its operations geographically, with Toronto being the first non-U.S. site for its clinical trials.
Collection
[
|
...
]